Edition:
United Kingdom

People: Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

61.03USD
9:00pm BST
Change (% chg)

$-1.15 (-1.85%)
Prev Close
$62.18
Open
$62.33
Day's High
$62.33
Day's Low
$60.78
Volume
13,664
Avg. Vol
17,689
52-wk High
$73.31
52-wk Low
$43.50

Schamroth, Michael 

Mr. Michael Schamroth is an Independent Director of Biospecifics Technologies Corp. He is currently a director on the Board and has served as a director of the Company since 2004. He has been a partner of M. Schamroth & Sons in New York City for over 40 years. As a principal in this fourth-generation international diamond house, Mr. Schamroth has extensive experience in dealing with all aspects of the trade, from manufacturing to sales. He has been a member of the Diamond Manufacturers and Importers Association since 1964, and has served on the Nominating and Building Committees of the Diamond Dealers Club. In addition, Mr. Schamroth has served as a member of the Board of South Nassau Communities Hospital since 1976, the Board of the Winthrop-South Nassau University Health System since 1993 and the Board of Sound Bank of North Carolina since 2002. He has been a member of the Miami University Business Advisory Board since 1984 and served as its Chairman from 1987-1988. He received his B.S. in Business from Miami University, Oxford, Ohio. He has been nominated for re-election at the 2019 Annual Meeting. The Company believes that Mr. Schamroth is qualified to serve as a member of our Board because of his business and professional experience.

Basic Compensation

Total Annual Compensation, USD 45,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 45,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ronald Law

375,000

Patrick Caldwell

--

Mark Wegman

50,000

Toby Wegman

22,000

Jennifer Chao

340,150

Paul Gitman

45,000
As Of  31 Dec 2018